PT  - JOURNAL ARTICLE
AU  - Razo, Martha
AU  - Pishgar, Maryam
AU  - Darabi, Houshang
TI  - Deep Learning Model for Mortality Prediction of ICU Patients with Paralytic Ileus
AID  - 10.1101/2021.10.06.21264665
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.10.06.21264665
4099  - http://medrxiv.org/content/early/2021/10/07/2021.10.06.21264665.short
4100  - http://medrxiv.org/content/early/2021/10/07/2021.10.06.21264665.full
AB  - Background Paralytic Ileus (PI) patients in the Intensive Care Unit (ICU) are at a significant risk of death. Prediction of at-risk patients for mortality after 24 hours of admission of ICU PI patients is important to increase the life expectancy of PI patients.Methods and Results The proposed framework, DLMP (Deep Learning Model for Mortality Prediction of ICU Patients with PI) is a powerful deep learning model consisting of six total unique clinical lab items and two demographics as inputs to a Neural Network(NN) of only two neuron layers. Using the Medical Information Mart for Intensive Care III (MIMIC-III) dataset of 1,017 ICU PI patients, the DLMP resulted in the best prediction performance with an AUC score of 0.866.Conclusion The proposed approach is capable of modeling the mortality of ICU patients after 24 hours admission using only six unique total clinical data and two demographics with a simple NN architecture. DLMP framework significantly improves the outcome prediction compared to the process mining and machine learning models. The proposed DLMP has the potential of allowing clinicians to create targeted interventions that reduce mortality for PI patients in an ICU setting.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research is partially supported by the grant T42OH008672, funded by the Centers for Disease Control and Prevention. Its contents are the sole responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:MIMIC III dataset is a publically available dataI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesMIMIC III dataset is a publically available data